Clinical Trials Directory

Trials / Completed

CompletedNCT03951792

Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects

Status
Completed
Phase
Study type
Observational
Enrollment
220 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Researchers are trying to determine whether certain microbiome cause cancer or whether they are part of the microbiome in the gut due to the presence of cancer.

Detailed description

The purpose of this research is to learn about how the gastrointestinal bacteria (microbiome) can contribute to colon cancer, and how it may change due to colon cancer. In addition, we are going to study the features of the microbiome that can help predict recovery after colon resection. To do this, we are going to compare the microbiome from subjects with colon cancer to subjects without colon cancer. Study participation involves collection of stool samples before and after your surgery, as well as samples of residual (left-over) colon tissue from your surgery. We would also like to collect optional samples from your follow-up colonoscopy. You may be in the study for up to 5 years.

Conditions

Timeline

Start date
2019-05-28
Primary completion
2024-03-15
Completion
2024-03-15
First posted
2019-05-15
Last updated
2024-04-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03951792. Inclusion in this directory is not an endorsement.